Allfunds Group PLC (0AAL)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 14.94 |
|---|---|
| 52-week range | 6.12 – 14.94 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +147.3% / +210.0% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 354.6% |
| Worst drawdown (1 year) | -43.5% |
| Average daily value traded | 9.73M EUR |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Allfunds Group is a fund distribution and open-architecture platform that connects asset managers with distributors such as banks, insurers and financial advisers. It provides dealing, settlement and data services for mutual funds and other investment products, helping institutions access and administer a broad range of funds. The company is based in Madrid, Spain, and serves clients across many countries, acting as an intermediary layer between fund providers and the institutions that place client money.
On this site Allfunds Group PLC appears as a stock on the London Exchange (UK), code 0AAL, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Allfunds Group PLC (0AAL) trades on the London Exchange in UK. It last closed at EUR 14.94 on 23 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,153 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 147.3% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 39.6% | ||
| From 52-week high | 0.0% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 75.4% | ||
| 12-month return, skipping the last month | 147.3% | ||
| Stability (higher is calmer) | 13 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 354.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.5% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 9.73M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | +75.4% |
| 1 year | +147.3% |
| 3 years | +210.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 12.66 / 10.70 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.35 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | GBP 0.2000 |
| 8 May 2025 | GBP 0.1310 |
| 9 May 2024 | GBP 0.0935 |
| 11 May 2023 | GBP 0.0900 |
| 25 Apr 2022 | GBP 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.